ArticleBiomedical chromatography : BMC2026
A Robust Stability-Indicating RP-HPLC Method for Simultaneous Determination of Widely Used Pharmaceutical and Cosmetic Preservatives.
Article in Biomedical chromatography : BMC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmaceutical and cosmetic preservatives play a critical role in inhibiting microbial contamination, preventing chemical degradation, and maintaining product efficacy and safety throughout the shelf life. Given their functional importance, comparable to that of active pharmaceutical ingredients, it is essential to monitor their quality using advanced analytical techniques. Among the most commonly employed seven varieties of preservatives in industry are 2,4-dihydroxybenzoic acid, 4-hydroxybenzoic acid, 3,4-dihydroxybenzoic acid, benzyl alcohol, benzaldehyde, phenol, sodium benzoate, methylparaben, and propylparaben, either individually or in combination. The present study focuses on the development and validation of a stability-indicating, reverse-phase high-performance liquid chromatography method for simultaneous quantification of these seven preservatives and their impurities, benzaldehyde and phenol, a total of nine components. The method demonstrates high selectivity, sensitivity, accuracy, and precision, and meets the validation criteria outlined in International Council for Harmonization (ICH) guidelines. Optimal chromatographic resolution was achieved using a Phenomenex Luna C18 column, dual-wavelength UV detection at 254 and 230 nm, and a gradient mobile phase consisting of 0.1% orthophosphoric acid and acetonitrile. The method was established within a range of 1.5-45.0μg/mL concentration for all components. The validated method is suitable for routine quality control testing across various pharmaceutical and cosmetic formulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.